Filing Details
- Accession Number:
- 0001140361-13-034298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-27 15:41:31
- Reporting Period:
- 2013-08-23
- Filing Date:
- 2013-08-27
- Accepted Time:
- 2013-08-27 15:41:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
275053 | Natures Sunshine Products Inc | NATR | Pharmaceutical Preparations (2834) | 870327982 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1459276 | Jamon Jarvis | 75 East 1700 South Provo UT 84606 | Evp, Gen Counsel, Sec, Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-23 | 700 | $7.38 | 700 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-23 | 700 | $18.17 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-08-26 | 5,044 | $7.38 | 5,044 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-08-26 | 153 | $9.87 | 5,197 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-26 | 5,197 | $18.10 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-08-23 | 700 | $0.00 | 700 | $7.38 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-08-26 | 5,044 | $0.00 | 5,044 | $7.38 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-08-26 | 153 | $0.00 | 153 | $9.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,044 | 2021-01-03 | No | 4 | M | Direct | |
0 | 2021-01-03 | No | 4 | M | Direct | |
41,847 | 2020-05-10 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.23, inclusive. The reporting person undertakes to provide Nature's Sunshine Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- On August 8, 2013, the Issuer declared a one-time cash dividend of $1.50 per share to shareholders of record as of August 19, 2013, to be paid on August 29, 2013. As a result, pursuant to anti-dilution provisions of the Issuer's stock incentive plans, the exercise price of all outstanding options were reduced by $1.50.
- The option vests in three equal installments based on satisfaction of certain performance criteria. The performance criteria for 2/3 of the options were determined to have been met on 3/1/12, resulting in vesting of the option with respect to 20,000 shares. The remainder of the option vested with respect to 10,000 shares on 8/21/12 when the performance criteria for the final 1/3 of the option were determined to have been met.
- On May 10, 2010, the reporting person was granted an option to purchase 42,000 shares of common stock. The option vests in three equal installments based on satisfaction of certain performance criteria. The performance criteria for two-thirds of the options were determined to have been met on 3/1/12, resulting in vesting of the option with respect to 28,000 shares. The remainder of the option vested with respect to 14,000 shares on 8/21/12 when the performance criteria for the final one-third of the options were determined to have been met.